Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 18 2013
Print RSS Feed

Breaking News

Related Searches:
Pii Expands Manufacturing Capabilities

April 26, 2011
Pharmaceutics International Inc. (Pii) has added an MG2G140 capsule filler to its solid oral GMP manufacturing area, expanding its existing commercial manufacturing capabilities.  Read More »
Pharmacyclics Achieves HDAC Milestone

April 26, 2011
Pharmacyclics, Inc. has received a $7 million milestone payment from Les Laboratoires Servier (Servier) for its histone deacetylase (HDAC) inhibitor, PCI-24781 / S 78454.   Read More »
Harlan Laboratories

April 26, 2011
Manuela Leone has been appointed president of contract research services (CRS) for Harlan Laboratories, Inc.  Read More »
Novavax, Inc.

April 26, 2011
Louis Fries III, M.D., has been appointed vice president, clinical and medical affairs, and Jane Halpern, Ph.D., has been appointed vice president of regulatory affairs at Novavax, Inc.   Read More »
Pharmatek Adds Spray Drying Capabilities

April 25, 2011
Pharmatek Laboratories, Inc. has added spray drying to its drug formulation and manufacturing capabilities with the purchase of a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture.  Read More »
Sanofi Gains Menactra Indication for Infants

April 25, 2011
Sanofi Pasteur received approval from the FDA for the expanded use of meningococcal conjugate vaccine Menactra in infants and children 9 to 23 months of age.  Read More »
Bayer, OncoMed Enter Clinical Mfg Pact

April 25, 2011
OncoMed Pharmaceuticals and Bayer HealthCare have expanded their collaboration under which Bayer will manufacture clinical supplies of a second Wnt inhibitor.  Read More »
GVK Bio Licenses Biomarker Database to FDA

April 25, 2011
GVK Biosciences has extended its Clinical Biomarker Database (GOBIOM) license to the Biomarker Qualification Group of the FDA.   Read More »
Cytovance Biologics

April 25, 2011
Bernhard Hampl, Ph.D., has been appointed co-chairman of Cytovance Biologics, Inc.   Read More »
Financial Report: Amgen 1Q11

April 21, 2011
U.S. product sales in the quarter increased 4% to $2.8 billion.  Read More »
Financial Report: Biogen Idec 1Q11

April 21, 2011
Growth in the quarter was primarily driven by Tysabri revenues, up 15% to $251 million, and Avonex sales, up 8% to $642 million.   Read More »
Financial Report: Gilead Sciences 1Q11

April 21, 2011
Sales of Atripla were up 7% to $744.5 million. Sales of Truvada were up 2% to $673.1 million.   Read More »
Financial Report: ICON 1Q11

April 21, 2011
Gross business wins in the quarter were $329 million, representing a book to bill of 1.43.  Read More »
ICON, ACRONET Sign Alliance in Japan

April 21, 2011
ICON and ACRONET Corp. have signed an alliance agreement under which the two companies will collaborate to offer global and Japanese pharmaceutical clients a full range of clinical development capabilities to manage trials both regionally and globally.  Read More »
Financial Report: Elan 1Q11

April 20, 2011
Tysabri revenues were up 23% to $245.2 million in the quarter, offsetting revenue loss from legacy products including Azactam, Prialt, Maxipime and Skelaxin, which contributed $38.7 million in 1Q10.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: